Scientists for the first time have used CRISPR gene editing to halt the progression of Duchenne muscular dystrophy (DMD) in a large mammal, according to a study by UT Southwestern that provides a strong indication that a lifesaving treatment may be in the pipeline.
The research published in Science documents unprecedented improvement in the muscle fibers of dogs with DMD – the most common fatal genetic disease in children, caused by a mutation that inhibits the production of dystrophin, a protein critical for muscle function.
Researchers used a single-cut gene-editing technique to restore dystrophin in muscle and heart tissue by up to 92 percent of normal levels. Scientists have estimated a 15 percent threshold is needed to significantly help patients.
“Children with DMD often die either because their heart loses the strength to pump, or their diaphragm becomes too weak to breathe,” said Dr. Eric Olson, Director of UT Southwestern’s Hamon Center for Regenerative Science and Medicine. “This encouraging level of dystrophin expression would hopefully prevent that from happening.”
DMD, which affects one in 5,000 boys, leads to muscle and heart failure, and premature death by the early 30s. Patients are forced into wheelchairs as their muscles degenerate and eventually onto respirators as their diaphragms weaken. No effective treatment exists, though scientists have known for decades that a defect in the dystrophingene causes the condition.
The Science study establishes the proof-of-concept for single-cut gene editing in dystrophic muscle and represents a major step toward a clinical trial. Already Dr. Olson’s team has corrected DMD mutations in mice and human cells by making single cuts at strategic points of the mutated DNA.
The latest research applied the same technique in four dogs that shared the type of mutation most commonly seen in DMD patients. Scientists used a harmless virus called adeno-associated virus (AAV) to deliver CRISPR gene-editing components to exon 51, one of the 79 exons that comprise the dystrophin gene.
CRISPR edited the exon, and within several weeks the missing protein was restored in muscle tissue throughout the body, including 92 percent correction in the heart and 58 percent in the diaphragm, the main muscle needed for breathing.
“Our strategy is different from other therapeutic approaches for DMD because it edits the mutation that causes the disease and restores normal expression of the repaired dystrophin,” said Dr. Leonela Amoasii, lead author of the study and Assistant Instructor of Molecular Biology in Dr. Olson’s lab. “But we have more to do before we can use this clinically.”
The lab will next conduct longer-term studies to measure whether the dystrophin levels remain stable and to ensure the gene edits do not have adverse side effects.
Dr. Olson hopes the next step beyond dogs is a clinical trial, which would be among several that UT Southwestern’s gene therapy center aims to launch in the coming years to address numerous deadly childhood diseases.
In the meantime, Dr. Olson’s recent work has spawned a biotechnology company, Exonics Therapeutics Inc., which is working to further optimize and bring this technology to the clinic. Exonics intends to extend the approach to additional DMD mutations, as well as other neuromuscular diseases. Exonics has licensed the technology from UT Southwestern.
The Latest on: Duchenne muscular dystrophy
via Google News
The Latest on: Duchenne muscular dystrophy
- Releasing brakes: Potential new methods for Duchenne muscular dystrophy therapieson February 24, 2020 at 1:26 pm
Researchers identified a group of small molecules that may open the door to developing new therapies for Duchenne muscular dystrophy (DMD), an as-yet-uncured disease that results in devastating muscle ...
- DMD Muscle Cell (image)on February 24, 2020 at 1:15 pm
A stained cell modeling Duchenne muscular dystrophy used in the study. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing ...
- Barbecue event raises money for teen with Duchenne muscular dystrophyon February 23, 2020 at 12:35 pm
Embargo: Greenville-Spartanburg, SC-Asheville, NC** The Hendersonville, NC, community rallied around Javon Clark,13, who was diagnosed with Duchenne muscular dystrophy. HENDERSONVILLE, NC (WLOS ) — ...
- New drugs for Duchenne Muscular Dystrophy excite : Key takeaway from Assessment Analysison February 21, 2020 at 8:47 am
This intelligence report provides a comprehensive analysis of the Global Duchenne Muscular Dystrophy Market. This includes Investigation of past progress, ongoing market scenarios, and future ...
- Catabasis Pharmaceuticals to Present Edasalonexent at the XVIII International Conference on Duchenne and Becker Muscular Dystrophyon February 21, 2020 at 5:00 am
BOSTON--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that it will present the edasalonexent program in Phase 3 ...
- Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery systemon February 19, 2020 at 1:23 pm
Present address: Exonics Therapeutics, 490 Arsenal Way, Watertown, MA 02472, USA. See allHide authors and affiliations Duchenne muscular dystrophy (DMD) is a lethal neuromuscular disease caused by ...
- Florida couple seeks cure for grandson’s rare dystrophyon February 19, 2020 at 3:46 am
Palm Beach grandparents Don and Nancy Herzog are battling the clock to defeat a foe that threatens their 4-year-old grandson – a progressive disease called Duchenne muscular dystrophy that takes aim ...
- PTC Therapeutics Launches Sixth Annual STRIVE Awards Program for Advocacy Organizations in Duchenne Muscular Dystrophyon February 18, 2020 at 5:00 am
SOUTH PLAINFIELD, N.J., Feb. 18, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. PTCT today announced the launch of the sixth annual STRIVE grant awards ...
- ‘Beating the odds’ of muscular dystrophyon February 13, 2020 at 6:58 am
Noah McRitchie is a quadriplegic due to a condition called Duchenne muscular dystrophy, which makes attending college a challenge, both in and out of the classroom. Despite this adversity, the ...
- Gene Editing for Muscular Dystrophyon February 12, 2020 at 10:06 pm
As a result, there is a loss of mobility and premature muscle failure. There are several forms of Muscular Dystrophy; Duchenne Muscular Dystrophy, Becker, Myotonic, Facioscapulohumeral, Congenital, ...
via Bing News